Clinical trial
Deep Diabetic Foot Wound Treatment With Hydrogel Including 3% Sodium Pentaborate Pentahydrate
NCT02241811 is registered in ClinicalTrials.gov with SB Istanbul Education and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deep Diabetic Foot Wound Treatment With Hydrogel Including 3% Sodium Pentaborate Pentahydrate
- Lead sponsor
- SB Istanbul Education and Research Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- December 31, 2023
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wound healing